In describing what causes Athlete’s Foot, it might be wise to mention the usual etiological suspects and how tinea pedis is different from the organisms for which the new drug was indicated.

Also, there is some doubt in one’s mind that itraconazole Sporonox would be used to treat Athlete’s Foot at several dollars a tablet.

After reading the linked article, it merely seems as if the company is being slapped for failing to get FDA-approved ads into print. Not such a bad idea to attempt to start policing the printed copy; there’s a lot that drug manufacturers must attempt to get away with if there is no policy in place to run the final draft by the FDA. You’d think that Johnson & Johnson would’ve not been involved in this kind of stunt, though. Must be someone new or change in leadership in the organization?

Current score: 1 (to vote for this comment, please visit the site)